CalciMedica, Inc.·4

Jul 2, 9:48 PM ET

Stauderman Kenneth A. 4

4 · CalciMedica, Inc. · Filed Jul 2, 2025

Insider Transaction Report

Form 4
Period: 2025-07-01
Stauderman Kenneth A.
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2025-07-01$1.85/sh+1,000$1,8501,000 total(indirect: By Spouse)
Holdings
  • Common Stock

    11,944

Documents

1 file
  • 4
    form4-07032025_010721.xmlPrimary